BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 16, 2013
View Archived Issues
Novel transgenic pig model of familial hypercholesterolemia
Read More
Vertex Pharmaceuticals synthesizes new protein kinase inhibitors
Read More
Argos Therapeutics enrolls first patients in phase III ADAPT study
Read More
Researchers at Amgen present novel TRPM8 antagonists
Read More
The Wisconsin Alumni Research Foundation patents novel vitamin D analogues
Read More
Celecoxib shows promise as adjunctive treatment in children with autism
Read More
AstraZeneca and Vanderbilt University enter collaboration
Read More
Galapagos delivers second candidate drug to Janssen Pharmaceutica
Read More
French grant awarded for development of epicutaneous pediatric RSV vaccine
Read More
Four NIH-supported studies focus on new treatments for Alzheimer's disease
Read More
CorMedix signs marketing agreement with MKM Co-Pharma for Neutrolin
Read More
Cytos updates on phase IIb allergic asthma study
Read More
Tysabri label update sought from the FDA and EMA
Read More
Detection of endometrial and ovarian cancers through DNA screening of Pap smears
Read More
European approval for Amyvid diagnostic radiopharmaceutical
Read More
FDA accepts for filing Tarceva sNDA
Read More
Unigene Laboratories designs polypeptides with anti-inflammatory activity
Read More
Isis Pharmaceuticals patents antisense modulators of FGFR-4
Read More
European approval for new 800-mg tablet of Prezista
Read More
Novel GnRH receptor antagonists emerge from Bayer R&D
Read More
New antidiabetic agents described in Metabolic Solutions Development patent
Read More
Zenobia Therapeutics develops novel LRRK2 inhibitors
Read More